ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 208 filers reported holding CONMED CORP in Q4 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of CONMED CORP
ValueSharesWeighting
Q4 2020$280,000
-97.4%
2,500
-98.3%
0.00%
-100.0%
Q2 2020$10,678,000
+148.3%
148,329
+97.5%
0.02%
+66.7%
Q1 2020$4,300,000
+40.3%
75,088
+174.0%
0.01%
+71.4%
Q4 2019$3,064,000
-81.4%
27,400
-86.1%
0.01%
-82.1%
Q1 2019$16,430,000
+12.7%
197,523
-13.0%
0.04%
+2.6%
Q4 2018$14,574,000
-19.3%
227,002
-0.5%
0.04%
-7.3%
Q3 2018$18,065,000
+160.3%
228,042
+140.5%
0.04%
+141.2%
Q2 2018$6,941,00094,8200.02%
Other shareholders
CONMED CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Hood River Capital Management LLC 448,126$38,346,0001.80%
HealthCor Management, L.P. 455,190$38,951,0001.51%
Champlain Investment Partners, LLC 1,452,360$124,278,0001.04%
J. Goldman & Co LP 162,771$13,928,0000.96%
Granahan Investment Management 189,925$16,252,0000.80%
PURA VIDA INVESTMENTS, LLC 50,000$4,279,0000.65%
OAK RIDGE INVESTMENTS LLC 102,797$8,797,0000.61%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 78,722$6,736,0000.54%
MOODY ALDRICH PARTNERS LLC 23,834$2,039,0000.52%
361 CAPITAL LLC 30,901$2,644,0000.47%
View complete list of CONMED CORP shareholders